DNASE1L3 and hepatocellular carcinoma: The mRNA levels of DNASE1L3 in HCC tissues were significantly lower than that in normal samples, and the overall survival (OS) and progression‐free survival (PFS) of patients with high DNASE1L3 expression were better than those of patients with low DNASE1L3 expression (Figure 1A, B).